The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Apple Robert F since 2012.
This trader's CIK number is 1054942.
At the time of last reporting, Apple Robert F was the President & CEO of Antares Pharma, Inc.. (stock ticker symbol ATRS).
Also see all insider trading activities at Antares Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ATRS | 0 | $0 | 587,460 | $2,914,898 | 345,500 | $470,207 |
| 2019 | ATRS | 0 | $0 | 366,524 | $1,712,696 | 466,524 | $1,117,915 |
| 2018 | ATRS | 0 | $0 | 43,000 | $161,250 | 125,500 | $90,335 |
| 2017 | ATRS | 0 | $0 | 40,000 | $120,073 | 40,000 | $66,000 |
| 2017 | ATRS | 60,000 | $43,200 | 0 | $0 | 60,000 | $73,800 |
| 2014 | ATRS | 0 | $0 | 10,000 | $50,000 | 10,000 | $4,700 |
| 2013 | ATRS | 0 | $0 | 172,000 | $713,593 | 172,000 | $80,840 |
| 2012 | ATRS | 0 | $0 | 25,000 | $100,000 | 25,000 | $11,750 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-17 | ATRS | Option Ex | 5,519 | 2.62 | 14,459 |
| 2021-02-18 | ATRS | Option Ex | 250,000 | .88 | 220,000 |
| 2021-02-17 | ATRS | Sale | 5,519 | 4.75 | 26,215 |
| 2021-02-18 | ATRS | Sale | 491,960 | 5.00 | 2,461,275 |
| 2021-02-10 | ATRS | Sale | 7,278 | 4.75 | 34,570 |
| 2021-02-09 | ATRS | Sale | 49,129 | 4.75 | 233,362 |
| 2021-02-08 | ATRS | Sale | 33,574 | 4.75 | 159,476 |
| 2021-02-10 | ATRS | Option Ex | 7,278 | 2.62 | 19,068 |
| 2021-02-09 | ATRS | Option Ex | 49,129 | 2.62 | 128,717 |
| 2021-02-08 | ATRS | Option Ex | 33,574 | 2.62 | 87,963 |
| 2019-12-10 | ATRS | Option Ex | 58,524 | 3.96 | 231,755 |
| 2019-12-09 | ATRS | Option Ex | 308,000 | 2.52 | 776,160 |
| 2019-12-10 | ATRS | Sale | 58,524 | 4.76 | 278,340 |
| 2019-12-09 | ATRS | Sale | 308,000 | 4.66 | 1,434,356 |
| 2019-11-11 | ATRS | Option Ex | 100,000 | 1.10 | 110,000 |
| 2018-08-21 | ATRS | Option Ex | 43,000 | .47 | 20,210 |
| 2018-08-21 | ATRS | Sale | 43,000 | 3.75 | 161,250 |
| 2018-05-11 | ATRS | Option Ex | 82,500 | .85 | 70,125 |
| 2017-04-04 | ATRS | Option Ex | 37,000 | 1.65 | 61,050 |
| 2017-04-05 | ATRS | Option Ex | 3,000 | 1.65 | 4,950 |
| 2017-04-04 | ATRS | Sale | 37,000 | 3.00 | 111,073 |
| 2017-04-05 | ATRS | Sale | 3,000 | 3.00 | 9,000 |
| 2017-12-27 | ATRS | Option Ex | 60,000 | 1.23 | 73,800 |
| 2016-03-18 | ATRS | Buy | 60,000 | .72 | 43,200 |
| 2014-01-10 | ATRS | Sale | 10,000 | 5.00 | 50,000 |
| 2014-01-10 | ATRS | Option Ex | 10,000 | .47 | 4,700 |
| 2013-10-14 | ATRS | Option Ex | 22,000 | .47 | 10,340 |
| 2013-10-14 | ATRS | Sale | 22,000 | 5.05 | 111,210 |
| 2013-06-04 | ATRS | Sale | 28,600 | 4.03 | 115,115 |
| 2013-06-03 | ATRS | Sale | 86,400 | 4.01 | 346,809 |
| 2013-06-04 | ATRS | Option Ex | 28,600 | .47 | 13,442 |
| 2013-06-03 | ATRS | Option Ex | 86,400 | .47 | 40,608 |
| 2013-05-06 | ATRS | Option Ex | 10,000 | .47 | 4,700 |
| 2013-05-06 | ATRS | Sale | 10,000 | 4.02 | 40,160 |
| 2013-01-08 | ATRS | Option Ex | 25,000 | .47 | 11,750 |
| 2013-01-08 | ATRS | Sale | 25,000 | 4.01 | 100,299 |
| 2012-12-04 | ATRS | Option Ex | 25,000 | .47 | 11,750 |
| 2012-12-04 | ATRS | Sale | 25,000 | 4.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Apple Robert F (President & CEO of Antares Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.